<?xml version="1.0" encoding="UTF-8" ?>
<HYPOTHESES>
	<H h_id="146">
<text>Merck is a US pharmaceutical giant.</text>
<ref doc_id="AFP_ENG_20041105.0545" s_id="1">
US pharmaceutical giant Merck on Friday disputed the conclusion of the British medical weekly The Lancet that the arthritis drug Vioxx should have been pulled from the market four years earlier.
</ref>
</H>
	<H h_id="147">
<text>Merck is the maker of Vioxx.</text>
<ref doc_id="AFP_ENG_20041118.0554" s_id="5">
Merck, the maker of Vioxx, which was approved by the FDA in 1999, voluntarily took the drug off the market in September.
</ref>
</H>
	<H h_id="148">
<text>Vioxx is a pain drug.</text>
<ref doc_id="AFP_ENG_20041109.0409" s_id="1">
Drugs giant Merck and Co.'s shares slumped Tuesday after the firm revealed civil and criminal investigations into the sale of its pain drug Vioxx.
</ref>
</H>
	<H h_id="149">
<text>Vioxx is an arthritis drug.</text>
<ref doc_id="AFP_ENG_20041105.0545" s_id="1">
US pharmaceutical giant Merck on Friday disputed the conclusion of the British medical weekly The Lancet that the arthritis drug Vioxx should have been pulled from the market four years earlier.
</ref>
</H>
	<H h_id="151">
<text>Vioxx was approved by the FDA in 1999. </text>
<ref doc_id="AFP_ENG_20041118.0554" s_id="5">
Merck, the maker of Vioxx, which was approved by the FDA in 1999, voluntarily took the drug off the market in September.
</ref>
</H>
	<H h_id="153">
<text>Merck withdrew Vioxx from the market.</text>
<ref doc_id="LTW_ENG_20041113.0022" s_id="1">
Merck said the Justice Department had launched a criminal investigation into its handling of Vioxx, the blockbuster pain-killing drug that it withdrew from the market after a study found long-term use increased the risk of heart attacks and strokes.
</ref>
</H>
	<H h_id="154">
<text>Merck pulled Vioxx off the market on September 30, 2004.</text>
<ref doc_id="APW_ENG_20041108.0409" s_id="1">
Drug maker Merck &amp; Co. said that the Securities and Exchange Commission and the Justice Department are looking into the company's handling of Vioxx, the blockbuster arthritis drug it pulled off the market Sept. 30 after safety studies showed it increased the risk of heart attacks.
</ref>
</H>
	<H h_id="155">
<text>A study found use of Vioxx increased the risk of heart attacks.</text>
<ref doc_id="LTW_ENG_20041113.0022" s_id="1">
Merck said the Justice Department had launched a criminal investigation into its handling of Vioxx, the blockbuster pain-killing drug that it withdrew from the market after a study found long-term use increased the risk of heart attacks and strokes.
</ref>
</H>
	<H h_id="160">
<text>Results from a clinical trial prompted Merck to pull Vioxx from the market.</text>
<ref doc_id="NYT_ENG_20041117.0307" s_id="1">
Nearly a year before Merck received results from the clinical trial that prompted the company to pull its painkiller Vioxx from the market, the company received preliminary results from a separate study of patient records that also apparently indicated the drug posed cardiovascular risks.
</ref>
</H>
	<H h_id="161">
<text>Some patients, after taking Vioxx for 18 months, developed serious cardiovascular problems.</text>
<ref doc_id="NYT_ENG_20041117.0307" s_id="5">
When it withdrew the drug from the market, Merck cited a long-term trial showing that some patients, after taking Vioxx for 18 months, developed serious cardiovascular problems.
</ref>
</H>
	<H h_id="163">
<text>The stock price of Merck fell down.</text>
<ref doc_id="LTW_ENG_20041204.0028" s_id="1">
With its stock price down sharply since pulling the painkiller Vioxx off the market, Merck &amp; Co. adopted a plan guaranteeing large severance packages to 230 top executives if the company merges or is taken over.
</ref>
</H>
	<H h_id="164">
<text>The Lancet concluded that Vioxx should have been pulled from the market four years earlier.</text>
<ref doc_id="AFP_ENG_20041105.0545" s_id="1">
US pharmaceutical giant Merck on Friday disputed the conclusion of the British medical weekly The Lancet that the arthritis drug Vioxx should have been pulled from the market four years earlier.
</ref>
</H>
	<H h_id="165">
<text>Merck disputed the conclusion of The Lancet.</text>
<ref doc_id="AFP_ENG_20041105.0545" s_id="1">
US pharmaceutical giant Merck on Friday disputed the conclusion of the British medical weekly The Lancet that the arthritis drug Vioxx should have been pulled from the market four years earlier.
</ref>
</H>
	<H h_id="166">
<text>Merck revealed civil and criminal investigations into the sale of Vioxx.</text>
<ref doc_id="AFP_ENG_20041109.0409" s_id="1">
Drugs giant Merck and Co.'s shares slumped Tuesday after the firm revealed civil and criminal investigations into the sale of its pain drug Vioxx.
</ref>
</H>
	<H h_id="167">
<text>The Securities and Exchange Commission and the Justice Department are looking into Merck's handling of Vioxx.</text>
<ref doc_id="APW_ENG_20041108.0409" s_id="1">
Drug maker Merck &amp; Co. said that the Securities and Exchange Commission and the Justice Department are looking into the company's handling of Vioxx, the blockbuster arthritis drug it pulled off the market Sept. 30 after safety studies showed it increased the risk of heart attacks.
</ref>
</H>
	<H h_id="168">
<text>The pension fund of New York State filed a federal lawsuit against Merck. </text>
<ref doc_id="NYT_ENG_20041130.0209" s_id="1">
The pension fund of New York State filed a federal lawsuit Monday against Merck &amp; Co. that accused Merck of misleading shareholders about the safety of its now-withdrawn arthritis pain drug, Vioxx.
</ref>
</H>
	<H h_id="169">
<text>A federal lawsuit accused Merck of misleading shareholders about the safety of Vioxx.</text>
<ref doc_id="NYT_ENG_20041130.0209" s_id="1">
The pension fund of New York State filed a federal lawsuit Monday against Merck &amp; Co. that accused Merck of misleading shareholders about the safety of its now-withdrawn arthritis pain drug, Vioxx.
</ref>
</H>
	<H h_id="170">
<text>Merck  adopted a plan guaranteeing large severance packages to top executives if the company merges or is taken over.</text>
<ref doc_id="LTW_ENG_20041204.0028" s_id="1">
With its stock price down sharply since pulling the painkiller Vioxx off the market, Merck &amp; Co. adopted a plan guaranteeing large severance packages to 230 top executives if the company merges or is taken over.
</ref>
</H>
</HYPOTHESES>
